Milena M. McLaughlin
Milena M. McLaughlin publishes mostly in Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology, on topics such as HIV/AIDS drug development and treatment, Pharmaceutical Economics and Policy and Antibiotic Resistance in Bacteria.
- World rank
- #1,685,464 of 7,710,434 ranked researchers
- Rank in United States
- #521,624 of 1,627,098
- Works
- 73
- Citations
- 1.8k
- Citations per work
- 25.3
What does Milena M. McLaughlin research?
Milena M. McLaughlin's work is mostly in Medicine (38%), Economics, Econometrics and Finance (7%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3750.4%
- Health Sciences2837.9%
- Medicine2837.9%
- Social Sciences57.0%
- Life Sciences34.7%
- 1Public Health, Environmental and Occupational Health12% of their works
- 2Infectious Diseases12% of their works
- 3Epidemiology9% of their works
- 4Economics and Econometrics7% of their works
- 5Pharmacology6% of their works
- 6Molecular Medicine5% of their works
Research topics
- HIV/AIDS drug development and treatment
- Pharmaceutical Economics and Policy
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Bacterial Identification and Susceptibility Testing
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical studies and practices
- Antibiotic Use and Resistance
Which keywords describe Milena M. McLaughlin's research?
The keywords of their largest research topics: Drug Resistance, Antibiotic Resistance, Antiretroviral Therapy, HIV Infection, Drug Development Costs, Generic Drugs, Antibiotic Pharmacokinetics and Critically Ill Patients.
- Global Health
- Pediatric Pharmacokinetics
- Polypharmacy
- Microorganism Identification
- Multidrug-Resistant Bacteria
- Critically Ill Patients
- Generic Drugs
- HIV Infection
- Antibiotic Resistance
- Drug Resistance
- Antiretroviral Therapy
- Drug Development Costs
- Antibiotic Pharmacokinetics
- ESKAPE Pathogens
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Inappropriate Medication Use
- Off-Label Drug Use
- Antimicrobial Stewardship
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Drug Resistance182 topics
- Antibiotic Resistance162 topics
- Antiretroviral Therapy121 topic
- HIV Infection121 topic
- Drug Development Costs111 topic
- Generic Drugs111 topic
- Antibiotic Pharmacokinetics101 topic
- Critically Ill Patients101 topic
- ESKAPE Pathogens101 topic
- Multidrug-Resistant Bacteria101 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry91 topic
- Microorganism Identification91 topic
- Inappropriate Medication Use81 topic
- Polypharmacy81 topic
- Off-Label Drug Use71 topic
- Pediatric Pharmacokinetics71 topic
- Antimicrobial Stewardship61 topic
- Global Health61 topic
Where does Milena M. McLaughlin work?
Milena M. McLaughlin's main affiliation in the publication record is Midwestern University, United States.
How many publications and citations does Milena M. McLaughlin have?
OpenAlex counts 73 works and 1,849 citations for Milena M. McLaughlin, an h-index of 19, ranking #1,685,464 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Milena M. McLaughlin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.